The surcharge is expected to be adjusted quarterly based on the cost of sulfur used for its production facility in Green River, Wyoming.
The surcharge will be calculated using the amount of increase or decrease in the cost of sulfur compared to the first quarter of 2008, and factoring the amount of sulfur used to manufacture sodium sulfite and sodium metabisulfite.
According to Mike Wood, Business Manager Sulfite Products, “Due to the unprecedented rise in the cost of sulfur, a key building block of all our sulfite products, this surcharge must be passed on to our customers in the most fair and rapid way possible, to ensure continued supply.”
SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels, Belgium. Its companies employ some 28,000 people in 50 countries. In 2007, its consolidated sales amounted to EUR 9.6 billion, generated by its three sectors of activity: Chemicals, Plastics and Pharmaceuticals (NYSE Euronext: SOLB.BE – Bloomberg: SOLB.BB – Reuters: SOLBt.BR). Solvay is listed on the NYSE Euronext stock exchange in Brussels. Details are available at www.solvay.com.